Wockhardt Limited

Wockhardt Limited - PE Ratioverified

WOCKPHARMA.NS

Price:

$1912.9

Market Cap:

$310.83B

Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-da...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2002-07-01

Stock Exchange

NSE

Ticker

WOCKPHARMA.NS

The PE Ratio as of August 2026 (TTM) for Wockhardt Limited (WOCKPHARMA.NS) is 145.91

According to Wockhardt Limited’s latest financial reports and current stock price. The company's current PE Ratio is 145.91. This represents a change of 106.76% compared to the average of 70.57 of the last 4 quarters.

Wockhardt Limited (WOCKPHARMA.NS) Historical PE Ratio (quarterly & annually)

How has WOCKPHARMA.NS PE Ratio performed in the past?

The mean historical PE Ratio of Wockhardt Limited over the last ten years is -52.08. The current 145.91 PE Ratio has changed -28119.09% with respect to the historical average. Over the past ten years (40 quarters), WOCKPHARMA.NS's PE Ratio was at its highest in in the December 2024 quarter at 389.24. The PE Ratio was at its lowest in in the September 2017 quarter at -472.51.

Quarterly (TTM)
Annual

Average

-52.08

Median

-14.18

Minimum

-482.63

Maximum

89.61

Wockhardt Limited (WOCKPHARMA.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Wockhardt Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.49%

Maximum Annual PE Ratio = 89.61

Minimum Annual Increase = -194.70%

Minimum Annual PE Ratio = -482.63

Quarterly (TTM)
Annual
YearPE RatioChange
202689.61-118.57%
2025-482.632.49%
2024-18.65370.22%
2023-3.97-69.54%
2022-13.02-15.04%
2021-15.3342.51%
2020-10.76-32.86%
2019-16.0227.62%
2018-12.55-66.45%
2017-37.43-194.70%

Wockhardt Limited (WOCKPHARMA.NS) Average PE Ratio

How has WOCKPHARMA.NS PE Ratio performed in the past?

The current PE Ratio of Wockhardt Limited (WOCKPHARMA.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-137.22

5-year avg

-85.73

10-year avg

-52.08

Wockhardt Limited (WOCKPHARMA.NS) PE Ratio vs. Peers

How is WOCKPHARMA.NS’s PE Ratio compared to its peers?

Wockhardt Limited’s PE Ratio is greater than Eris Lifesciences Limited (29.36), greater than Eris Lifesciences Limited (29.36), greater than AstraZeneca Pharma India Limited (114.85), greater than AstraZeneca Pharma India Limited (114.85), greater than Neuland Laboratories Limited (59.82), greater than Neuland Laboratories Limited (59.82), greater than Piramal Enterprises Limited (67.04), greater than J. B. Chemicals & Pharmaceuticals Limited (53.41), greater than J. B. Chemicals & Pharmaceuticals Limited (53.41), greater than Alembic Pharmaceuticals Limited (23.57),

Build a custom stock screener for Wockhardt Limited (WOCKPHARMA.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wockhardt Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Wockhardt Limited (WOCKPHARMA.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Wockhardt Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Wockhardt Limited's PE Ratio?

How is the PE Ratio calculated for Wockhardt Limited (WOCKPHARMA.NS)?

What is the highest PE Ratio for Wockhardt Limited (WOCKPHARMA.NS)?

What is the 3-year average PE Ratio for Wockhardt Limited (WOCKPHARMA.NS)?

What is the 5-year average PE Ratio for Wockhardt Limited (WOCKPHARMA.NS)?

How does the current PE Ratio for Wockhardt Limited (WOCKPHARMA.NS) compare to its historical average?